These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7378119

  • 1. The influence of clofibrate on lipid and protein components of very low density lipoproteins in type IV hyperlipoproteinaemia.
    Naruszewicz M, Szostak WB, Cybulska C, Kozłowska M, Chotkowska E.
    Atherosclerosis; 1980 Apr; 35(4):383-92. PubMed ID: 7378119
    [Abstract] [Full Text] [Related]

  • 2. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG, Lavy A, Aviram M, Zinder O.
    Atherosclerosis; 1980 Aug; 36(4):461-9. PubMed ID: 7417365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B, Lithell H, Gustafsson IB, Borberg J.
    Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

  • 11. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS.
    J Clin Endocrinol Metab; 1982 Jun 04; 54(6):1210-5. PubMed ID: 7076797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Jun 04; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M, Kuźmińska A, Chotkowska E, Kurjata P, Polakowska M, Broda G, Rywik S.
    Pol Arch Med Wewn; 1992 Mar 04; 87(3):149-56. PubMed ID: 1523145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.